Back
Arcellx Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
38
ACLX
Arcellx
Last Price:
52.71
Seasonality Move:
33.89%
Buy
67
MDGL
Madrigal Pharmaceuticals
Last Price:
229.49
Seasonality Move:
-4.02%
Sell
38
Arcellx (ACLX)
is a Sell
Is Arcellx a Buy, Sell or Hold?
- The current Arcellx [ACLX] share price is $52.69. The Score for ACLX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ACLX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $229.84. The Score for MDGL is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $229.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing slight buying pressure.
ACLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.21 | Sell |
| Relative Strength Index (14 RSI): | 38.89 | Sell |
| Chaikin Money Flow: | -324634 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.64 - 61.24) | Sell |
| Bollinger Bands (100): | (53.29 - 67.09) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.57 | Sell |
| Relative Strength Index (14 RSI): | 53.13 | Buy |
| Chaikin Money Flow: | 132283 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (208.26 - 245.1) | Buy |
| Bollinger Bands (100): | (213.09 - 251.85) | Sell |
ACLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.91 | Buy |
| 20-day SMA: | 54.6 | Sell |
| 50-day SMA: | 62.86 | Sell |
| 200-day SMA: | 49.48 | Buy |
| 8-day EMA: | 52.49 | Buy |
| 20-day EMA: | 55.11 | Sell |
| 50-day EMA: | 58.95 | Sell |
| 200-day EMA: | 51.86 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 206.69 | Buy |
| 20-day SMA: | 221.85 | Buy |
| 50-day SMA: | 240.36 | Sell |
| 200-day SMA: | 201.32 | Buy |
| 8-day EMA: | 213.98 | Buy |
| 20-day EMA: | 220.49 | Buy |
| 50-day EMA: | 229.3 | Buy |
| 200-day EMA: | 216.05 | Buy |
Arcellx Earnings Growth & ACLX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.68 per share, and a decrease next year of $0.14 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.24 per share, a decrease next quarter of $0.71 per share, a decrease this year of $4.24 per share, and an increase next year of $8.97 per share.
Arcellx Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||